Haemonetics Corporation HAE
NYSE · United States · Health Technology
$104.37-0.93 (-0.88%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q1 2026 | 2026-08-06 | 1.14 | 1.08 | +5.9% | $339.38M | +3.5% | +5.1%$83.60→$87.84 |
| Q1 2026 | 2026-05-07 | 1.29 | 1.28 | +0.8% | — | — | +4.7%$52.67→$55.12 |
| Q4 2025 | 2026-02-05 | 1.31 | 1.27 | +3.1% | — | — | -10.0%$65.95→$59.34 |
| Q3 2025 | 2025-11-06 | 1.27 | 1.12 | +13.4% | — | — | +34.8%$50.72→$68.36 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.